Consistent with the hypothesis that increased INa,L downstream of CaMKII-dependent phosphorylation of Nav1.5 increases susceptibility to obesity-induced AF, treatment with mexiletine eliminated PACs and AT/AF in WT-HFD mice (Fig. 2A–C). The gene discussed is CAMK2G; the disease is obesity disorder.